94 related articles for article (PubMed ID: 38558822)
1. Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.
Meng Y; Yu Z; Wu Y; Du T; Chen S; Meng F; Su N; Ma Y; Li X; Sun S; Zhang G
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28301281
[TBL] [Abstract][Full Text] [Related]
2. Multiomic Analysis Reveals Disruption of Cholesterol Homeostasis by Cannabidiol in Human Cell Lines.
Guard SE; Chapnick DA; Poss ZC; Ebmeier CC; Jacobsen J; Nemkov T; Ball KA; Webb KJ; Simpson HL; Coleman S; Bunker E; Ramirez A; Reisz JA; Sievers R; Stowell MHB; D'Alessandro A; Liu X; Old WM
Mol Cell Proteomics; 2022 Oct; 21(10):100262. PubMed ID: 35753663
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol and Aza-BODIPY Coencapsulation for Photodynamic Therapy Enhancement in Liver Cancer Cells.
Kampaengsri S; Muangsopa P; Pangjantuk A; Chansaenpak K; Lai RY; Noisa P; Kamkaew A
ACS Appl Bio Mater; 2024 May; ():. PubMed ID: 38776245
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
Wang S; Wang Z
Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
[TBL] [Abstract][Full Text] [Related]
5. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
6. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
Li Y; Sharma A; Hoffmann MJ; Skowasch D; Essler M; Weiher H; Schmidt-Wolf IGH
Front Immunol; 2024; 15():1268652. PubMed ID: 38558822
[TBL] [Abstract][Full Text] [Related]
7. High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells.
Garofano F; Schmidt-Wolf IGH
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471216
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I-II non-small cell lung cancer after curative surgery.
Huang J; Zhao X; Zhang Z; Yang S; Chen X; Shen C; Wang L; Qi Y; Zhang Y
Cytotherapy; 2023 Feb; 25(2):202-209. PubMed ID: 36379882
[TBL] [Abstract][Full Text] [Related]
9. A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.
Li Y; Sharma A; Wu X; Weiher H; Skowasch D; Essler M; Schmidt-Wolf IGH
Front Oncol; 2022; 12():713476. PubMed ID: 35646685
[TBL] [Abstract][Full Text] [Related]
10. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
[TBL] [Abstract][Full Text] [Related]
11. A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells.
Garofano F; Sharma A; Abken H; Gonzalez-Carmona MA; Schmidt-Wolf IGH
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409142
[TBL] [Abstract][Full Text] [Related]
12. Correlation of
Pietrzak J; Wosiak A; Szmajda-Krygier D; Świechowski R; Łochowski M; Pązik M; Balcerczak E
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509417
[TBL] [Abstract][Full Text] [Related]
13. DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine.
Zhang G; Wang Z; Song P; Zhan X
EPMA J; 2022 Dec; 13(4):649-669. PubMed ID: 36505890
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models.
Domingos LB; Silva NR; Chaves Filho AJM; Sales AJ; Starnawska A; Joca S
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421839
[TBL] [Abstract][Full Text] [Related]
15. Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.
Peng Y; Qi W; Luo Z; Zeng Q; Huang Y; Wang Y; Sharma A; Schmidt-Wolf IGH; Liao F
Front Oncol; 2022; 12():973109. PubMed ID: 36185301
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
